Multiple Sclerosis Clinical Trial

Vitamin D Pilot Study in Patients With Multiple Sclerosis

Summary

Phase 1 study of 19-nor Vitamin D in relapsing-remitting MS. Primary measure is MRI.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

relapsing remitting MS

Exclusion Criteria:

MRI contraindicated

Study is for people with:

Multiple Sclerosis

Phase:

Phase 1

Study ID:

NCT01257958

Recruitment Status:

Completed

Sponsor:

University of Wisconsin, Madison

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

UW-Madison
Madison Wisconsin, 53792, United States

How clear is this clinincal trial information?

Study is for people with:

Multiple Sclerosis

Phase:

Phase 1

Study ID:

NCT01257958

Recruitment Status:

Completed

Sponsor:


University of Wisconsin, Madison

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider